Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DR26F3NNT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,536
Award facts
- Contract value 100% obligated
- $5,535.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,535.71 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Trelegy Ellipta is a combination respiratory therapy medication commonly used in treating chronic obstructive pulmonary disease, reflecting the breadth of pharmaceutical commodities delivered through this contract vehicle to support Defense Health Agency requirements and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3NNT?
SPE2DR26F3NNT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F3NNT worth?
The government has obligated $5,536 on SPE2DR26F3NNT.
Is contract SPE2DR26F3NNT an order under another contract?
Yes. SPE2DR26F3NNT is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3NNT competed?
The extent of competition for SPE2DR26F3NNT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award